Literature DB >> 28461020

Stroke characterization in Sun Saharan Africa: Congolese population.

Emmanuel Bakilo Limbole1, Julien Magne2, Philippe Lacroix3.   

Abstract

BACKGROUND: Stroke is the second cause of death worldwide and over than 80% of deaths occurs in developing countries. However, its characteristics in the Democratic Republic of Congo (DRC) are poorly defined. This study aimed to describe the key features of stroke in a hospital population of Kinshasa in DRC and to assess the frequency of cardiovascular risk factors and their impact on target organs.
METHODS: A descriptive study was carried out from three hospitals in Kinshasa between January and April 2013. Cardiovascular risk factors, clinical and biological data were collected during the study period. The study involved 166 patients aged 18years and over.
RESULTS: The mean age of patients was 59.6±12.3years, the sex ratio for male of 1.9. Stroke was ischemic in 66% of cases. Hypertension was the most frequent cardiovascular risk factor (84.3%), followed by high blood cholesterol (45.2%).The etiologies of ischemic stroke (TOAST classification) were dominated by lacunas (38.5%) and embolic heart diseases (12.8%). The origin was unknown in 45.9% of cases. Coma was observed in 37% of patients on admission and was the main independent prognostic factor of mortality, which was 19.3%. Left ventricular hypertrophy and renal failure were found respectively in 64.7% and 34% of patients.
CONCLUSION: This study found a growing increase of ischemic stroke in a society where hemorrhagic type used to be the most common, a high rate of hypertension, hypercholesterolemia and diabetes, indicative of a fast epidemiological transition.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular risk factors; Democratic Republic of Congo; Stroke; Sub-Saharan Africa

Mesh:

Year:  2017        PMID: 28461020     DOI: 10.1016/j.ijcard.2017.04.063

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa.

Authors:  Rufus O Akinyemi; Mayowa O Owolabi; Masafumi Ihara; Albertino Damasceno; Adesola Ogunniyi; Catherine Dotchin; Stella-Maria Paddick; Julius Ogeng'o; Richard Walker; Raj N Kalaria
Journal:  Brain Res Bull       Date:  2018-05-25       Impact factor: 4.077

2.  Minimal Setting Stroke Unit in a Sub-Saharan African Public Hospital.

Authors:  Fode A Cisse; Charlotte Damien; Aissatou K Bah; M L Touré; M Barry; A B Djibo Hamani; Michel Haba; Fode M Soumah; Gilles Naeije
Journal:  Front Neurol       Date:  2019-08-07       Impact factor: 4.003

3.  Stroke in Djibouti.

Authors:  Mohamed Ahmed Nour; Saloua Mrabet; Mouled Ali Maidal; Alya Gharbi; Youssef Abida; Amira Souissi; Amina Gargouri; Imen Kacem; Amina Nasri; Riadh Gouider
Journal:  Afr J Emerg Med       Date:  2022-04-12

4.  Stroke Mortality in Kenya's Public Tertiary Hospitals: A Prospective Facility-Based Study.

Authors:  Lydia Kaduka; Erastus Muniu; Chrispine Oduor; Jane Mbui; Robai Gakunga; Judith Kwasa; Sylvanus Wabwire; Nathan Okerosi; Anne Korir; Scot Remick
Journal:  Cerebrovasc Dis Extra       Date:  2018-06-12

5.  Stroke distribution patterns and characteristics in Kenya's leading public health tertiary institutions: Kenyatta National Hospital and Moi Teaching and Referral Hospital.

Authors:  Lydia Kaduka; Anne Korir; Chrispine Owuor Oduor; Judith Kwasa; Jane Mbui; Sylvanos Wabwire; Robai Gakunga; Nathan Okerosi; Yvonne Opanga; Isaac Kisiang'ani; Mercy Rotich Chepkurui; Erastus Muniu; Scot C Remick
Journal:  Cardiovasc J Afr       Date:  2018 Mar/Apr       Impact factor: 1.167

6.  Predictors of stroke favorable functional outcome in Guinea, results from the Conakry stroke registry.

Authors:  Fode Abass Cisse; Noémie Ligot; Kaba Conde; Djigué Souleymane Barry; Lamine Mohamed Toure; Mamadi Konate; Mohamed Fode Soumah; Karinka Diawara; Mohamed Traore; Gilles Naeije
Journal:  Sci Rep       Date:  2022-01-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.